170 related articles for article (PubMed ID: 27999837)
1. Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels.
Zhang W; Zhang Z; Tung CH
Chem Commun (Camb); 2017 Jan; 53(4):779-782. PubMed ID: 27999837
[TBL] [Abstract][Full Text] [Related]
2. Redox-responsive cisplatin nanogels for anticancer drug delivery.
Zhang W; Tung CH
Chem Commun (Camb); 2018 Jul; 54(60):8367-8370. PubMed ID: 29995047
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates.
Cai S; Alhowyan AA; Yang Q; Forrest WC; Shnayder Y; Forrest ML
J Drug Target; 2014 Aug; 22(7):648-57. PubMed ID: 24892741
[TBL] [Abstract][Full Text] [Related]
4. Aquated cisplatin and heparin-pluronic nanocomplexes exhibiting sustainable release of active platinum compound and NCI-H460 lung cancer cell antiproliferation.
Tong NA; Nguyen TP; Cuu Khoa N; Tran NQ
J Biomater Sci Polym Ed; 2016; 27(8):709-20. PubMed ID: 26886825
[TBL] [Abstract][Full Text] [Related]
5. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
[TBL] [Abstract][Full Text] [Related]
6. The design and characterization of a novel beta-casein nano-vehicle loaded with platinum anticancer drug for drug delivery.
Divsalar A; Razmi M; Saboury AA; Seyedarabi A
Anticancer Agents Med Chem; 2014; 14(6):892-900. PubMed ID: 24521150
[TBL] [Abstract][Full Text] [Related]
7. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G
Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514
[TBL] [Abstract][Full Text] [Related]
8. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
[TBL] [Abstract][Full Text] [Related]
9. A dual location stimuli-responsive degradation strategy of block copolymer nanocarriers for accelerated release.
Chan N; Khorsand B; Aleksanian S; Oh JK
Chem Commun (Camb); 2013 Sep; 49(68):7534-6. PubMed ID: 23863915
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer.
Ohta S; Hiramoto S; Amano Y; Emoto S; Yamaguchi H; Ishigami H; Kitayama J; Ito T
Mol Pharm; 2017 Sep; 14(9):3105-3113. PubMed ID: 28806513
[TBL] [Abstract][Full Text] [Related]
11. Production of Cisplatin-Incorporating Hyaluronan Nanogels via Chelating Ligand-Metal Coordination.
Ohta S; Hiramoto S; Amano Y; Sato M; Suzuki Y; Shinohara M; Emoto S; Yamaguchi H; Ishigami H; Sakai Y; Kitayama J; Ito T
Bioconjug Chem; 2016 Mar; 27(3):504-8. PubMed ID: 26781684
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
Shi Y; Goodisman J; Dabrowiak JC
Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
[TBL] [Abstract][Full Text] [Related]
13. Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects.
Liu R; Hou W; Li J; Gou X; Gao M; Wang H; Zhang Y; Deng H; Yang X; Zhang W
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132074. PubMed ID: 38705320
[TBL] [Abstract][Full Text] [Related]
14. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
Yu H; Gou S; Wang Z; Chen F; Fang L
Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
16. A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy.
Lv Y; Ding G; Zhai J; Guo Y; Nie G; Xu L
Colloids Surf B Biointerfaces; 2013 Oct; 110():411-8. PubMed ID: 23759382
[TBL] [Abstract][Full Text] [Related]
17. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6.
Nukolova NV; Baklaushev VP; Abakumova TO; Mel'nikov PA; Abakumov MA; Yusubalieva GM; Bychkov DA; Kabanov AV; Chekhonin VP
Bull Exp Biol Med; 2014 Aug; 157(4):524-9. PubMed ID: 25110098
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid-chitosan hybrid nanoliposomes promoting cell entry for drug delivery against cervical cancer.
Saesoo S; Bunthot S; Sajomsang W; Gonil P; Phunpee S; Songkhum P; Laohhasurayotin K; Wutikhun T; Yata T; Ruktanonchai UR; Saengkrit N
J Colloid Interface Sci; 2016 Oct; 480():240-248. PubMed ID: 27442151
[TBL] [Abstract][Full Text] [Related]
20. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
